Showing 221 - 240 results of 2,171 for search 'Who's Who in the World', query time: 0.06s Refine Results
  1. 221

    THE TRADITION OF NEW PERSONALITY UPBRINGING IN THE HISTORY OF RUSSIAN EDUCATION by V. I. Polishchuk

    Published 2015-03-01
    “…Not enough emphasis was placed on the inner world of people compared to their words, deeds and attitudes. …”
    Get full text
    Article
  2. 222

    Real-world outcomes of prophylactic cranial irradiation utilization and efficacy for patients with extensive-stage small cell lung cancer treated with consolidative thoracic radiot... by Abdul H. Lone, Rohan Salunkhe, Vijithan Sugumar, Luna J. Zhan, Xiang Y. Ye, Andrea Bezjak, John Cho, Meredith E. Giuliani, Andrew J. Hope, Alexander Sun, Srinivas Raman, Penelope A. Bradbury, Lawson Eng, Natasha B. Leighl, Frances A. Shepherd, Adrian Sacher, Geoffrey Liu, Benjamin H. Lok

    Published 2025-03-01
    “…We sought to evaluate the impact of PCI on the outcomes of ES-SCLC patients who were all treated with CTRT. Methods: A retrospective analysis of ES-SCLC patients without brain metastases who were all treated with CTRT between 2013–2021 at our institution was conducted. …”
    Get full text
    Article
  3. 223
  4. 224

    Brodalumab: Six-Year US Pharmacovigilance Report by Mark G. Lebwohl, John Y. Koo, April W. Armstrong, Bruce E. Strober, Soo Han Yoon, Nicole N. Rawnsley, Earl L. Goehring, Gina D. Mangin, Abby A. Jacobson

    Published 2024-11-01
    “…Abstract Introduction Brodalumab is a human interleukin-17 receptor A antagonist indicated for the treatment of moderate-to-severe plaque psoriasis in adult patients who are candidates for systemic therapy or phototherapy and have failed to respond or have lost response to other systemic therapies. …”
    Get full text
    Article
  5. 225

    Real-World Assessment of Weight Change in African American Females and Hispanics with HIV-1 After Initiating Integrase Strand-Transfer Inhibitors or Protease Inhibitors by Yen-Wen Chen, David Anderson, Christopher D. Pericone, Prina Donga

    Published 2022-01-01
    “…**Background:** Studies have shown an increase in weight among people living with HIV (PLWH) who initiated integrase strand transfer inhibitors (INSTI). …”
    Get full text
    Article
  6. 226
  7. 227
  8. 228
  9. 229

    The Impact of Baseline Risk Factors on the Incidence of Febrile Neutropenia in Breast Cancer Patients Receiving Chemotherapy with Pegfilgrastim Prophylaxis: A Real-World Data Analy... by Edward Li, Bridgette Kanz Schroader, David Campbell, Kim Campbell, Weijia Wang

    Published 2021-06-01
    “…This is particularly important during real-world study planning where potential missteps may lead to bias or confounding effects that render a study meaningless. …”
    Get full text
    Article
  10. 230

    Real-World Characterization of Toxicities and Medication Management in Recipients of CAR T-Cell Therapy for Relapsed or Refractory Large B-Cell Lymphoma in Nova Scotia, Canada by Jenna Shaw, Mahmoud Elsawy, Rachel Nielsen, Amye Michelle Harrigan, Tara T. DiCostanzo, Laura V. Minard

    Published 2024-12-01
    “…By day +100, the best objective response rate was 81.5% (44.4% complete responses). Patients who received CAR T-cell therapy in NS, Canada, experienced comparable toxicities and efficacy to those reported in pivotal clinical trials and other real-world experiences.…”
    Get full text
    Article
  11. 231

    The Association between Serum Level of Vitamin D and Inflammatory Biomarkers in Hospitalized Adult Patients: A Cross-Sectional Study Based on Real-World Data by Xiaomin Zhang, Zhiqi Chen, Yi Xiang, Yiquan Zhou, Molian Tang, Jun Cai, Xinyi Xu, Hongyuan Cui, Yi Feng, Renying Xu

    Published 2024-01-01
    “…We performed the current study based on real-world data from two teaching hospitals. Serum level of vitamin D (assessed by 25-hydroxyvitamin D) was evaluated within 2 days after admission. …”
    Get full text
    Article
  12. 232

    A Pragmatic Clinical Trial to Compare the Real-World Effectiveness of V-Go versus Standard Delivery of Insulin in Patients with Advanced Type 2 Diabetes by Mark J. Cziraky, Scott Abbott, Matt Nguyen, Kay Larholt, Elizabeth Apgar, Thomas Wasser, Poul Strange, Leon Shi, H. Courtenay Harrison, Beverly Everitt, Lynn Nowak

    Published 2019-03-01
    “…A cost of therapy analysis was completed on patients who had received comparable baseline T2DM treatment with multiple daily basal-bolus insulin injections (MDI). …”
    Get full text
    Article
  13. 233

    Very first real-world data on zongertinib use in non-small cell lung cancer patients with HER2 mutations: A brief report by Oliver Illini, Anna Sophie Lang-Stöberl, Hannah Fabikan, Christoph Weinlinger, Arschang Valipour, Maximilian J. Hochmair

    Published 2024-01-01
    “…Methods: We report real-world data on six consecutive patients with HER2-mutant NSCLC who received zongertinib through a named patient use program between December 2023 and June 2024. …”
    Get full text
    Article
  14. 234
  15. 235
  16. 236
  17. 237

    “It’s not what I saw, it’s not what I thought”: by Lindsey Dodd

    Published 2022-07-01
    “…This article draws on the oral history narratives of three people who were children in France during the Second World War to demonstrate their dissatisfactions with dominant versions of this past put forward in authoritative public discourse. …”
    Get full text
    Article
  18. 238

    « Ce n’est pas ce que j’ai vu, ce n’est pas ce que j’ai pensé»  by Lindsey Dodd

    Published 2022-07-01
    “…This article draws on the oral history narratives of three people who were children in France during the Second World War to demonstrate their dissatisfactions with dominant versions of this past put forward in authoritative public discourse. …”
    Get full text
    Article
  19. 239
  20. 240

    Real-world use of tafasitamab preceding CD19-directed chimeric antigen receptor T-cell therapy for relapsed or refractory diffuse large B-cell lymphoma by Narendranath Epperla, Loretta J. Nastoupil, Bruce Feinberg, John Galvin, Prathamesh Pathak, Theresa Amoloja, Danielle Gentile, Kim Saverno

    Published 2025-01-01
    “…This retrospective analysis examined characteristics and outcomes of adults with R/R DLBCL who received tafasitamab preceding CD19-directed chimeric antigen receptor T-cell (CAR-T) therapy in a real-world setting. …”
    Get full text
    Article